Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, Spyre Therapeutics Inc’s stock clocked out at $14.93, up 5.89% from its previous closing price of $14.10. In other words, the price has increased by $5.89 from its previous closing price. On the day, 0.66 million shares were traded.
Ratios:
To gain a deeper understanding of SYRE’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.06 and its Current Ratio is at 8.06. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on April 08, 2025, initiated with a Outperform rating and assigned the stock a target price of $45.
On March 18, 2025, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $27.
On September 04, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $45.Wedbush initiated its Outperform rating on September 04, 2024, with a $45 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 06 ’24 when Albers Jeffrey W. sold 6,700 shares for $36.76 per share. The transaction valued at 246,313 led to the insider holds 27,360 shares of the business.
Albers Jeffrey W. sold 300 shares of SYRE for $10,929 on Oct 25 ’24. The Director now owns 34,060 shares after completing the transaction at $36.43 per share. On Oct 25 ’24, another insider, SESSIONS, LLC, who serves as the Director of the company, bought 7,000 shares for $33.70 each.
Stock Price History:
Over the past 52 weeks, SYRE has reached a high of $40.49, while it has fallen to a 52-week low of $10.91. The 50-Day Moving Average of the stock is -4.50%, while the 200-Day Moving Average is calculated to be -38.07%.
Shares Statistics:
A total of 60.28M shares are outstanding, with a floating share count of 51.23M. Insiders hold about 15.12% of the company’s shares, while institutions hold 98.35% stake in the company.
